PRECLINICAL CHARACTERIZATION OF ABI-4334, A NOVEL, HIGHLY POTENT CORE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTIONXiang Xu,Michael Shen,Lida Guo,Ariel Tang,Nuruddin Unchwaniwala, Thilo J. Heckrodt,Min Zhong,Michael Walker,Michel Perron, William E. Delaney, Kathryn KitrinosHEPATOLOGY(2021)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要